HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 293 | 335 | 87.5% | |
| HF 4 | 2012 | 309 | 338 | 91.4% | |
| HF 4 | 2013 | 312 | 333 | 93.7% | |
| HF004 | 2014 | 165 | 173 | 95.4% | |
| HF004 | 2015 | 174 | 183 | 95.1% | |
| HF004 | 2016 | 170 | 182 | 93.4% | |
| HF004 | 2017 | 178 | 191 | 93.2% | |
| HF004 | 2018 | 187 | 196 | 95.4% | |
| HF004 | 2019 | 241 | 249 | 96.8% | |
| HF004 | 2020 | 270 | 285 | 94.7% | |
| HF006 | 2021 | 416 | 464 | 89.7% | |
| HF006 | 2022 | 592 | 642 | 92.2% | |
| HF006 | 2023 | 636 | 662 | 96.1% |
